Ionis Pharmaceuticals, Inc. Fair Value, Assets, Level 2 to Level 1 Transfers, Amount
Ionis Pharmaceuticals, Inc. (IONS) had Fair Value, Assets, Level 2 to Level 1 Transfers, Amount of $0 as of 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount · last filed 2019-03-01
- 2018-12-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2018-09-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2018-06-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2018-03-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-01 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-06 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-07 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-07 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-01 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-09 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-28 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-09 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-09 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-01 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |